CastleKnight Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

CastleKnight Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,000	Closed	-$606K	–	480
2025 Q3	$606K	Buy	+30,000	New	+$527K	0.01%	370
2024 Q3	–	Sell	-60,000	Closed	-$975K	–	404
2024 Q2	$975K	Sell	60,000 -60,000	-50%	-$924K	0.05%	218
2024 Q1	$1.69M	Buy	+120,000	New	+$1.51M	0.1%	143

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CastleKnight Management's TEVA Position: Q1 2026 in Review

CastleKnight Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2026, closing a stake of 245,200 shares — an estimated $7.65M sold.

CastleKnight Management first reported a position in TEVA in Q4 2023 and held it in 9 quarters. The position peaked at $12.7M in Q3 2025. 654 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

CastleKnight Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2026 after selling out during the quarter.
CastleKnight Management sold 245,200 Teva Pharmaceutical Industries Limited shares in Q1 2026, an estimated $7.65M.
CastleKnight Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2023 and held it in 9 quarters.
CastleKnight Management's Teva Pharmaceutical Industries Limited position peaked at $12.7M in Q3 2025.
654 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2026.

Based on CastleKnight Management's 13F filing for Q1 2026, filed 15 May 2026.